MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 27.12.2025
Centogene N.V. Zahlungsmittel 2011-2026 | CNTG
Zahlungsmittel Jährlich Centogene N.V.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.1 M | 36 M | 17.8 M | 48.2 M | 41.1 M | 9.22 M | 3.16 M | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 48.2 M | 3.16 M | 24.9 M |
Zahlungsmittel Vierteljährlich Centogene N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 42.7 M | 17.8 M | 25.7 M | 34.8 M | 45.2 M | 48.2 M | 28.7 M | 17.4 M | 33.4 M | 41.1 M | 6.06 M | 3.56 M | 5.14 M | 9.22 M | - | - | - | 3.16 M | - | - | - | 965 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 48.2 M | 965 K | 22.7 M |
Zahlungsmittel anderer Aktien in der Diagnostik & Forschung
| Name | Zahlungsmittel | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
50.2 M | $ 19.5 | - | $ 600 M | USA |
 |
Celcuity
CELC
|
166 M | $ 92.47 | - | $ 4.32 B | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 5.76 | - | $ 7.66 M | USA |
 |
Guardant Health
GH
|
378 M | $ 133.06 | - | $ 16.7 B | USA |
 |
Castle Biosciences
CSTL
|
117 M | $ 21.6 | - | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
15.1 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 23.12 | - | $ 1.23 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
647 M | $ 152.8 | - | $ 12 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Illumina
ILMN
|
1.42 B | $ 168.06 | - | $ 26 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.02 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 102.82 | - | $ 6.94 B | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 185.79 | - | $ 9.21 B | USA |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 180.48 | - | $ 24.3 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
497 M | $ 458.69 | - | $ 13.2 B | USA |
 |
NeoGenomics
NEO
|
160 M | $ 11.31 | - | $ 1.45 B | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
1.08 B | $ 222.1 | - | $ 30.4 B | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 19.75 | 3.73 % | $ 442 M | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.69 | - | $ 434 M | USA |
 |
Personalis
PSNL
|
124 M | $ 12.1 | - | $ 1.08 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.99 | -0.02 % | $ 24.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 7.01 | - | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
70.1 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.15 | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 260.97 | - | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 73.93 | - | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 482.03 | - | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.68 | - | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
129 M | $ 9.12 | - | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 196.12 | - | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
588 M | $ 376.47 | - | $ 22.4 B | USA |